Sandbox Reserved 595: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| Line 26: | Line 26: | ||
lipoproteins. J. Biol. Chem.271:19053–19057.</ref>'. This region is protease sensitive '<ref>Freiden, Carl and K. Garai. 2012. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease. PNAS 109(23):8913-8919.</ref>'. | lipoproteins. J. Biol. Chem.271:19053–19057.</ref>'. This region is protease sensitive '<ref>Freiden, Carl and K. Garai. 2012. Structural differences between apoE3 and apoE4 may be useful in developing therapeutic agents for Alzheimer’s disease. PNAS 109(23):8913-8919.</ref>'. | ||
[[Image:ApoE_Sandbox_Reserved_595.jpg|thumb|left|350px]] | [[Image:ApoE_Sandbox_Reserved_595.jpg|thumb|left|350px|Full Protein (Chou ''et al.'' 2005)]] | ||
ApoE exhibits extensive domain interactions. Hydrogen bonds and salt-bridges act to shield the major LDLR-binding region. This protein's unique topology regulates its tertiary structure in order to solely permit one conformation upon binding in a two-step manner. Lipid-free and partially lipidated ApoE are thwarted from prematurely binding to ApoE receptors by the tertiary structure. Therefore, the optimal receptor-binding affinity of fully lipidated ApoE is guaranteed. An active conformation for biding to members of the low-density lipoprotein receptor family is achieved through binding to lipids and HSPGs '<ref>Chen, J et al. 2011. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci USA 108(36):14813-8.</ref>'. | ApoE exhibits extensive domain interactions. Hydrogen bonds and salt-bridges act to shield the major LDLR-binding region. This protein's unique topology regulates its tertiary structure in order to solely permit one conformation upon binding in a two-step manner. Lipid-free and partially lipidated ApoE are thwarted from prematurely binding to ApoE receptors by the tertiary structure. Therefore, the optimal receptor-binding affinity of fully lipidated ApoE is guaranteed. An active conformation for biding to members of the low-density lipoprotein receptor family is achieved through binding to lipids and HSPGs '<ref>Chen, J et al. 2011. Topology of human apolipoprotein E3 uniquely regulates its diverse biological functions. Proc Natl Acad Sci USA 108(36):14813-8.</ref>'. | ||
| Line 55: | Line 55: | ||
==Lipid Metabolism== | ==Lipid Metabolism== | ||
The protein, apolipoprotein E, has an important role in lipid metabolism; principally, it serves as a carrier protein. ApoE combines with lipids in the body to form lipoprotein particles '<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>' '<ref>Reynolds, Dawn. Apolipoprotein E. www.chem.cuteu.edu/chem4400/sjbr/dan971.htm.</ref>'. These lipoprotein particles have hydrophobic lipids situated at the core and hydrophilic side chains made of amino acids '<ref>Reynolds, Dawn. Apolipoprotein E. www.chem.cuteu.edu/chem4400/sjbr/dan971.htm.</ref>'. Specifically, apoE is responsible for packaging cholesterol,other lipids, and fat soluble vitamins and transporting them systemically '<ref>Han X. 2010. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease. Mol Neurobiol 41(2-3): 97-106.</ref>''<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>'. | The protein, apolipoprotein E, has an important role in lipid metabolism; principally, it serves as a carrier protein. ApoE combines with lipids in the body to form lipoprotein particles '<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>' '<ref>Reynolds, Dawn. Apolipoprotein E. www.chem.cuteu.edu/chem4400/sjbr/dan971.htm.</ref>'. These lipoprotein particles have hydrophobic lipids situated at the core and hydrophilic side chains made of amino acids '<ref>Reynolds, Dawn. Apolipoprotein E. www.chem.cuteu.edu/chem4400/sjbr/dan971.htm.</ref>'. Specifically, apoE is responsible for packaging cholesterol,other lipids, and fat soluble vitamins and transporting them systemically '<ref>Han X. 2010. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease. Mol Neurobiol 41(2-3): 97-106.</ref>''<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>'. | ||
[[Image:ApoE_functions.jpg|thumb|left|350px|Various Functions of ApoE (Zhang ''et al.'' 2011)]] | |||
Synthesis of this protein primarily occurs in the liver; approximately three-fourths of plasma apoE is generated in the liver by hepatic parenchymal cells '<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>'. In this location, apoE is included as a major component of very-low density lipoproteins (VLDL) '<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>' '<ref>Reynolds, Dawn. Apolipoprotein E. www.chem.cuteu.edu/chem4400/sjbr/dan971.htm.</ref>'. VLDL serves to remove excess cholesterol from the blood and to carry it to the liver for processing. Thus, apoE acts as a cholesterol chaperone '<ref>Arold, S. et al. 2012. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Acta Neuropathol 123(1):39-52.</ref>'. Maintaining optimal levels of cholesterol is crucial for the prevention of disorders that affect the heart and blood levels '<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>'. Triglycerides are also transported to the liver tissue with the aid of VLDL '<ref>Reynolds, Dawn. Apolipoprotein E. www.chem.cuteu.edu/chem4400/sjbr/dan971.htm.</ref>'. ApoE is essential for the normal catabalism of triglyceride-rich lipoprotein constituents '<ref>Arold, S. et al. 2012. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Acta Neuropathol 123(1):39-52.</ref>'. In the plasma, apoE will associate with most lipoproteins, however, n the central nervous system, it mainly associates with high-density lipoproteins (HDL) '<ref>Han X. 2010. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease. Mol Neurobiol 41(2-3): 97-106.</ref>'. | Synthesis of this protein primarily occurs in the liver; approximately three-fourths of plasma apoE is generated in the liver by hepatic parenchymal cells '<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>'. In this location, apoE is included as a major component of very-low density lipoproteins (VLDL) '<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>' '<ref>Reynolds, Dawn. Apolipoprotein E. www.chem.cuteu.edu/chem4400/sjbr/dan971.htm.</ref>'. VLDL serves to remove excess cholesterol from the blood and to carry it to the liver for processing. Thus, apoE acts as a cholesterol chaperone '<ref>Arold, S. et al. 2012. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Acta Neuropathol 123(1):39-52.</ref>'. Maintaining optimal levels of cholesterol is crucial for the prevention of disorders that affect the heart and blood levels '<ref>Genetics Home Reference. 2013. APOE gene. Ghr.hlm.nih.gov/gene/APOE.</ref>'. Triglycerides are also transported to the liver tissue with the aid of VLDL '<ref>Reynolds, Dawn. Apolipoprotein E. www.chem.cuteu.edu/chem4400/sjbr/dan971.htm.</ref>'. ApoE is essential for the normal catabalism of triglyceride-rich lipoprotein constituents '<ref>Arold, S. et al. 2012. Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortex. Acta Neuropathol 123(1):39-52.</ref>'. In the plasma, apoE will associate with most lipoproteins, however, n the central nervous system, it mainly associates with high-density lipoproteins (HDL) '<ref>Han X. 2010. The pathogenic implication of abnormal interaction between apolipoprotein E isoforms, amyloid-beta peptides, and sulfatides in Alzheimer's disease. Mol Neurobiol 41(2-3): 97-106.</ref>'. | ||